EuroAPI Header EuroAPI Header

X

Find SRA737 manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

SRA737
Also known as: Cct245737, 1489389-18-5, Cct-245737, Qb6lnl4nf6, Sra737, Sra-737 [who-sdg]
Molecular Formula
C16H16F3N7O
Molecular Weight
379.34  g/mol
InChI Key
YBYYWUUUGCNAHQ-LLVKDONJSA-N
FDA UNII
QB6LNL4NF6

Chk1 Inhibitor SRA737 is an orally bioavailable inhibitor of checkpoint kinase 1 (chk1), with potential antineoplastic and chemosensitization activities. Upon oral administration, chk1 inhibitor SRA737 selectively binds to chk1, thereby preventing chk1 activity and abrogating the repair of damaged DNA. This may lead to an accumulation of damaged DNA, inhibition of cell cycle arrest, and induction of apoptosis. SRA737 may potentiate the cytotoxicity of DNA-damaging agents and reverse tumor cell resistance to chemotherapeutic agents. Chk1, an adenosine triphosphate (ATP)-dependent serine/threonine kinase overexpressed in a variety of cancer cell types, mediates cell cycle checkpoint control and is essential for DNA repair; it plays a key role in resistance to chemotherapeutic agents by repairing DNA damage.
1 2D Structure

SRA737

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-[[4-[[(2R)-morpholin-2-yl]methylamino]-5-(trifluoromethyl)pyridin-2-yl]amino]pyrazine-2-carbonitrile
2.1.2 InChI
InChI=1S/C16H16F3N7O/c17-16(18,19)12-8-25-14(26-15-9-22-10(4-20)5-24-15)3-13(12)23-7-11-6-21-1-2-27-11/h3,5,8-9,11,21H,1-2,6-7H2,(H2,23,24,25,26)/t11-/m1/s1
2.1.3 InChI Key
YBYYWUUUGCNAHQ-LLVKDONJSA-N
2.1.4 Canonical SMILES
C1COC(CN1)CNC2=CC(=NC=C2C(F)(F)F)NC3=NC=C(N=C3)C#N
2.1.5 Isomeric SMILES
C1CO[C@H](CN1)CNC2=CC(=NC=C2C(F)(F)F)NC3=NC=C(N=C3)C#N
2.2 Other Identifiers
2.2.1 UNII
QB6LNL4NF6
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 5-((4-((morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile

2. Cct245737

2.3.2 Depositor-Supplied Synonyms

1. Cct245737

2. 1489389-18-5

3. Cct-245737

4. Qb6lnl4nf6

5. Sra737

6. Sra-737 [who-sdg]

7. Pnt-737

8. Sra-737

9. 2-pyrazinecarbonitrile, 5-((4-(((2r)-2-morpholinylmethyl)amino)-5-(trifluoromethyl)-2-pyridinyl)amino)-

10. Unii-qb6lnl4nf6

11. Gtpl9187

12. Chembl4169078

13. Schembl15392098

14. Us9663503, Compound 1

15. Bdbm328993

16. Sra737; Pnt-737

17. Ex-a1607

18. Mfcd30489721

19. Nsc793726

20. Zinc205442186

21. Ccg-268393

22. Compound 4 [pmid: 27167172]

23. Cs-5863

24. Nsc-793726

25. Cct-245737?

26. Ac-36122

27. Bs-15458

28. Hy-18958

29. J3.603.159j

30. Q27075794

31. (r)5-((4-((morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile

32. (r)a?-((4-((morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile

33. 5-[(4-{[(2r)-morpholin-2-ylmethyl]amino}-5-(trifluoromethyl)pyridin-2-yl)amino]pyrazine-2-carbonitrile

34. 5-[[4-[[(2r)-morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]pyrazine-2-carbonitrile

35. 5-[[4-[[(2r)-morpholin-2-yl]methylamino]-5-(trifluoromethyl)pyridin-2-yl]amino]pyrazine-2-carbonitrile

2.4 Create Date
2013-12-02
3 Chemical and Physical Properties
Molecular Weight 379.34 g/mol
Molecular Formula C16H16F3N7O
XLogP31.1
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count11
Rotatable Bond Count5
Exact Mass379.13684265 g/mol
Monoisotopic Mass379.13684265 g/mol
Topological Polar Surface Area108 Ų
Heavy Atom Count27
Formal Charge0
Complexity526
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY